Provider News

Autism Research Study Enrolling Children Ages 2 1/2 to 7

April 3, 2024
Flyer for an autism research studyClick to enlarge (PDF).

Seattle Children’s has a new research study where participants receive an autism diagnostic evaluation and developmental testing. The study is enrolling children ages 2 1/2 to 7 who are suspected of having autism spectrum disorder (ASD) or who are typically developing. We are specifically seeking community provider support in recruiting typically developing children. Regardless of ASD status, all participants will receive developmental testing and their families will be provided information on their developmental milestones and level, which many families are curious about.

There are very few restrictions for who can participate. The study is in-person in Seattle and can take from two to four hours. Participants need to be physically able to sit in a chair, highchair or booster seat at a table and watch age-appropriate videos on a screen, have normal to corrected-to-normal vision and hearing, and be able to understand instructions presented in English. Children who already have an autism diagnosis are not eligible.

This study will examine if an investigational medical device, called the EarliPoint™ Evaluation for Autism Spectrum Disorder, can be used to diagnose autism. The device tracks where children are looking as they watch videos on a screen. The purpose of this study is to determine whether the device can provide comparable results to current diagnostic tests performed by clinicians. 

Please feel free to print and provide the study flyer to your patients who may qualify. See the study website or call 206-987-7502 for more information.